TrovaGene Inc  

(Public, NASDAQ:TROVU)   Watch this stock  
Find more results for TROVU
0.00 (0.00%)
Real-time:   12:25PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 8.02 - 20.00
Open     -
Vol / Avg. 0.00/9.00
Mkt cap 110.58M
P/E     -
Div/yield     -
EPS -0.57
Shares 1.67M
Beta     -
Inst. own 204%
Jan 12, 2015
Trovagene Inc at EBD Biotech Showcase
Dec 2, 2014
Trovagene Inc at Piper Jaffray Healthcare Conference
Nov 20, 2014
Trovagene Inc at Canaccord Genuity Medical Technologies & Diagnostics Forum
Nov 19, 2014
Trovagene Inc at Stifel Healthcare Conference
Nov 6, 2014
Q3 2014 Trovagene Inc Earnings Call
Nov 6, 2014
Q3 2014 Trovagene Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -9397.24% -4555.81%
Operating margin -6888.51% -4123.64%
EBITD margin - -4073.30%
Return on average assets -62.53% -60.85%
Return on average equity -145.43% -104.97%
Employees 21 -
CDP Score - -


United States - Map
+1-858-2175420 (Phone)
+1-858-2174768 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Liberty Bell Bank (Liberty Bell) is a New Jersey state-chartered commercial bank. Liberty Bell maintains banking offices in Cherry Hill, Moorestown and Evesham New Jersey. The Bank is chartered by the New Jersey Department of Banking and Insurance and insured by the Federal Deposit Insurance Corporation. The Bank provides financial services primarily to Camden and Burlington Counties, as well as surrounding counties in New Jersey and Southeastern Pennsylvania. The Bank�s lending can be summarized into seven primary segments: commercial real estate loans, commercial loans, residential construction loans, commercial construction loans, commercial lease backed loans, home equity loans and consumer loans. The Bank makes commercial, real estate and consumer loans to customers. A substantial portion of the loan portfolio is represented by loans in Southern New Jersey.

Officers and directors

Thomas H. Adams Jr., Ph.D. Independent Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Antonius P. Schuh Ph.D. Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Stephen L. Zaniboni Chief Financial Officer
Age: 54
Bio & Compensation  - Reuters
Mark Erlander Chief Scientific Officer
Bio & Compensation  - Reuters
Carl B. Feldbaum Esq Director
Age: 70
Bio & Compensation  - Reuters
Paul R. Billings M.D., Ph.D. Independent Director
Age: 62
Bio & Compensation  - Reuters
John P. Brancaccio Independent Director
Age: 66
Bio & Compensation  - Reuters
Gary S. Jacob Ph.D. Independent Director
Age: 67
Bio & Compensation  - Reuters
Rodney S. Markin M.D., Ph.D. Independent Director
Age: 57
Bio & Compensation  - Reuters